Superoxide reductases (SORs) are cysteinate-ligated non-heme iron enzymes 1 In situ deprotection and deprotonation of the new macrocyclic ligand cyclam-PrS-Ac‚4HCl, afforded [Fe II (cyclam-PrS)](BPh 4 ) (2) upon the addition of FeCl 2 and NaBPh 4 . Single crystals were grown from pentane/THF at -30°C. As shown in the ORTEP ( Figure  1 ), the Fe 2+ ion of 2 is ligated by three secondary amines, one tertiary amine, and a tethered apical thiolate in a square pyramidal geometry (τ ) 0.13) 5 resembling that of SOR. A related tertiary amine cyclam complex [Fe II (Me 3 -cyclam-EtS)] + (3) was recently reported 6 that reacts with H 2 O 2 to afford an Fe(IV)dO. 7 Like the SOR active site, 2 is high spin (S ) 2; µ eff ) 5.03 µ B (MeCN); 4.91 µ B (solid)). The Fe-S bond length in 2 (2.286(1) Å) falls in the usual range for synthetic Fe(II)-thiolates, 6, 8 but is slightly shorter than that of SOR (Fe-S ) 2.4 Å), the cysteinate sulfur of which is H-bonded to the protein backbone. 2a Addition of HOAc to metastable 4 at -78°C releases H 2 O 2 (as detected using an amplex red assay), and cleanly affords a new aqua blue species λ max ) 604 (1350) nm (Figure 3 ). When this reaction is monitored by EPR, the high-spin signal associated with 4 is replaced with a new low-spin signal at g ) 2.37, 2.30, 1.89. The ν O-O and ν Fe-O stretches disappear in the rRaman spectrum, and new stretches are observed at 339, 409, and 421 cm -1 . Although this aqua blue species proved too unstable to isolate, it was unambiguously identified by ESI-mass spectrometry as acetatebound [Fe III (cyclam-PrS)(OAc)] + (5), a model for Glu-bound SOR.
Addition of a sacrificial reductant (Cp 2 Co) to 5 at low temperatures (-78°C) regenerates 2, which then reacts with a second equivalent of O 2 -• to re-afford peroxo 4. Addition of a second equivalent of HOAc releases H 2 O 2 (Figure 4) , thereby mimicking the proposed SOR catalytic cycle involving glutamic acid, 2d,e,i and demonstrating that reduction of O 2 -• by 2 is catalytic. Thus far, five turnovers have been achieved.
The thiolate ligand and its trans positioning relative to the substrate appear to contribute significantly to the function of our biomimetic catalyst. First, the pendant thiolate arm of 2 causes the redox potential to shift anodically by +480 mV relative to [Fe II -(cyclam)(MeCN) 2 ] (from +700 to +220 mV vs SCE), making it better suited to promote superoxide reduction. Second, the trans thiolate changes the spin state from S ) 1 In conclusion, the data described herein indicate that like the enzyme, SOR intermediate-analogue 4 is better suited to promote Fe-O, as opposed to O-O, bond cleavage. This is in contrast to P450 and its analogue 3. Kinetics studies and studies aimed at determining the pK a of the proximal and distal peroxo oxygens of 4 are currently underway. 
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